When it comes to chronic kidney disease, early detection and whole-body support can make all the difference. In episode of the Partner Podcast, Dr. Beth talks with Dr. Nicole Sheehan about how nutrition, inflammation control, and cellular support tools like protomorphogens can fit into a multimodal plan for kidney patients. Tune in as they discuss how integrative medicine can transform the way we support renal health in our patients.
Sponsored by Standard Process
Resource:
Contact us:
Where to find us:
X: @cliniciansbrief
The Team:
- Beth Molleson, DVM - Host
- Taylor Argo- Producer, Sound Editing, & Project Manager, Brief Studio
References:
Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, Gobe GC. Promoting plant-based therapies for chronic kidney disease. J Evid Based Integr Med. 2022;27:2515690X221079688. doi:10.1177/2515690X221079688
Hall JA, Fritsch DA, Jewell DE, Burris PA, Gross KL. Cats with IRIS stage 1 and 2 chronic kidney disease maintain body weight and lean muscle mass when fed food having increased caloric density, and enhanced concentrations of carnitine and essential amino acids. Vet Rec. 2019;184(6):190. doi:10.1136/vr.104865
Raj D, Tomar B, Lahiri A, Mulay SR. The gut-liver-kidney axis: novel regulator of fatty liver associated chronic kidney disease. Pharmacol Res. 2020;152:104617. doi:10.1016/j.phrs.2019.104617
Kobayashi S, Kawarasaki M, Aono A, Cho J, Hashimoto T, Sato R. Renoprotective effects of docosahexaenoic acid in cats with early chronic kidney disease due to polycystic kidney disease: a pilot study. J Feline Med Surg. 2022;24(12):e505-e512. doi:10.1177/1098612X221136815
Jun M, Venkataraman V, Razavian M, et al. Antioxidants for chronic kidney disease. Cochrane Database Syst Rev. 2012;10(10):CD008176. doi:10.1002/14651858.CD008176.pub2